Elana van Brakel
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Pneumonia and Respiratory Infections, Antibiotics Pharmacokinetics and Efficacy, vaccines and immunoinformatics approaches
Most-Cited Works
- → Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis(2019)569 cited
- → Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis(2018)397 cited
- → Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis(2016)27 cited
- → Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial(2025)21 cited
- → Safety and Immunogenicity of the H56:IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial(2024)10 cited
- → Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis(2017)9 cited
- → Optimizing β-Lactams against Tuberculosis(2020)8 cited
- → Triplicate Sputum Cultures for Efficacy Evaluation of Novel Antituberculosis Regimens(2017)4 cited
- → The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis(2021)4 cited
- → 120. A Randomized Double-blind Trial Assessing the Efficacy of M72/AS01E Vaccine Against Pulmonary Tuberculosis Disease in Adults With Latent Mycobacterium tuberculosis Infection(2018)1 cited